Download presentation
Presentation is loading. Please wait.
Published byGwendoline McKenzie Modified over 5 years ago
1
Clinical T2-T3N0M0 Esophageal Cancer: The Risk of Node Positive Disease
Brendon M. Stiles, MD, Farooq Mirza, MD, Anthony Coppolino, MD, Jeffrey L. Port, MD, Paul C. Lee, MD, Subroto Paul, MD, Nasser K. Altorki, MD The Annals of Thoracic Surgery Volume 92, Issue 2, Pages (August 2011) DOI: /j.athoracsur Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions
2
Fig 1 Overall survival for the cohort, stratified by clinical T stage: blue line indicates cT2; green line indicates cT3. The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions
3
Fig 2 Overall survival of patients receiving induction therapy followed by surgery (green line) versus patients undergoing surgery alone (blue line [p = 0.465]). The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions
4
Fig 3 Overall survival of pN+ patients (green line) versus pN0 patients (blue line): 5-year estimates, 35.0% versus 72.1% (p = 0.003). The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.